Patent classifications
C07D501/54
INTERMEDIATES IN THE SYNTHESIS OF CEPHALOSPORIN COMPOUNDS
Described herein are crystalline forms of a compound of formula (III.sup.−), including toluene solvates off A TD-CLE, as well as processes for the preparation thereof and use thereof in the preparation of cephalosporin compounds such as ceftolozane. Provided herein is a crystalline form of a compound of formula (III.sup.−): wherein X is CI, Br, or I; and R1 and R2 are each independently an oxygen protecting group; processes for making the crystalline form, and use of said form in the synthesis of antibacterial cephalosporins such as ceftolozane.
Intermediates in the synthesis of cephalosporin compounds
Described herein are crystalline forms of a compound of formula (III), including toluene solvates of TATD-CLE, as well as processes for the preparation thereof and use thereof in the preparation of cephalosporin compounds such as ceftolozane.
Intermediates in the synthesis of cephalosporin compounds
Described herein are crystalline forms of a compound of formula (III), including toluene solvates of TATD-CLE, as well as processes for the preparation thereof and use thereof in the preparation of cephalosporin compounds such as ceftolozane.
INTERMEDIATES IN THE SYNTHESIS OF CEPHALOSPORIN COMPOUNDS
Described herein are crystalline forms of a compound of formula (III), including toluene solvates of TATD-CLE, as well as processes for the preparation thereof and use thereof in the preparation of cephalosporin compounds such as ceftolozane.
INTERMEDIATES IN THE SYNTHESIS OF CEPHALOSPORIN COMPOUNDS
Described herein are crystalline forms of a compound of formula (III), including toluene solvates of TATD-CLE, as well as processes for the preparation thereof and use thereof in the preparation of cephalosporin compounds such as ceftolozane.
Intermediates in the synthesis of cephalosporin compounds
Described herein are crystalline forms of a compound of formula (II), including toluene solvates off A TD-CLE, as well as processes for the preparation thereof and use thereof in the preparation of cephalosporin compounds such as ceftolozane. Provided herein is a crystalline form of a compound of formula (II): wherein X is CI, Br, or I; and R1 and R2 are each independently an oxygen protecting group; processes for making the crystalline form, and use of said form in the synthesis of antibacterial cephalosporins such as ceftolozane.